Factors influencing placebo effects in patients with psychosomatic disorders: Doctor-patient relationship, patient's motivation and expectation for drug therapy

Japanese Journal of Clinical Pharmacology and Therapeutics

Volumn 30, Issue 1, 1999, Pages 1-7

  Nakano, Shigeyuki ^a   Sugahara, Hideyo ^a   Sakamoto, Masaya ^a   Ozeki, Tetsurou ^a   Uemura, Naoto ^a   Nyu, Seiji ^a   Sunami, Yukiko ^a   Matsuki, Syunji ^a   Umetsuki, Megumi ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Doctor patient relationship; Expectation; Motivation; Nondrug factors; Placebo effect; Psychosomatic disorders

Indexed keywords

DIAZEPAM; ETIZOLAM; PLACEBO;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DOCTOR PATIENT RELATION; EXPECTATION; GOOD CLINICAL PRACTICE; HUMAN; MAJOR CLINICAL STUDY; MOTIVATION; PATIENT ATTITUDE; PSYCHOSOMATIC DISORDER; RISK FACTOR; STATISTICAL ANALYSIS;

EID: 0041326496     PISSN: 03881601     EISSN: None     Source Type: Journal    
DOI: 10.3999/jscpt.30.1     Document Type: Article

References (8)

1. Beecher, H.K.: The powerful placebo. JAMA 159: 1602 (1955).
2. Harrington, A.: The Placebo Effect-An interdisciplinary exploration. Harvard University Press (1997).
3. Rickels, K.: Non-specific factors in drug therapy of neurotic patients. Rickels, K. (Ed.): Non-specific Factors in Drug Therapy, Charles C. Thomas Springfield, Illinois, p.7 (1968).
4. Kirsch, I. and Rosadino, M.J.: Do double-bind studies with informed consent yield externally valid results? A empirical test. Psychopharmacology, 110: 437-442 (1993).
5. Kirsch, I. and Weixel, L.J.: Double-blind versus deceptive administration of a placebo. Behav. Neurosci., 102: 319-323 (1988).